Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder.
about
Overactive bladder: strategies to ensure treatment compliance and adherenceAssessment of cognitive safety in clinical drug developmentIntegrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignancies.Cost-effectiveness of mirabegron compared to tolterodine ER 4 mg for overactive bladder in Canada.Overactive bladder in the vulnerable elderlyAre aerobics trophic for cognition in late life?Treating overactive bladder in the elderly.Association between different anticholinergic drugs and subsequent dementia risk in patients with diabetes mellitus.Brain penetration of the OAB drug trospium chloride is not increased in aged mice.Rationale for the use of anticholinergic agents in overactive bladder with regard to central nervous system and cardiovascular system side effects.Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients.New horizons: urinary incontinence in older people.Urinary incontinence in frail elderly persons: Report from the 5th International Consultation on Incontinence.Review of the efficacy and safety of fesoterodine for treating overactive bladder and urgency urinary incontinence in elderly patients.The effects of antimuscarinic treatment on the cognition of spinal cord injured individuals with neurogenic lower urinary tract dysfunction: a prospective controlled before-and-after study.OnabotulinumtoxinA Treatment for Overactive Bladder in the Elderly: Practical Points and Future Prospects.Neurogenic lower urinary tract dysfunction: evaluation and management.Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysis.Antimuscarinic Medication Use in Elderly Patients with Overactive Bladder.Dealing with complex overactive bladder syndrome patient profiles with focus on fesoterodine: in or out of the EAU guidelines?An investigation of factors predicting the type of bladder antimuscarinics initiated in Medicare nursing homes residents.Safety and Effectiveness of Mirabegron in Patients with Overactive Bladder Aged ≥75 Years: Analysis of a Japanese Post-Marketing Study.Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder.Differential Prescribing of Antimuscarinic Agents in Older Adults with Cognitive Impairment.Evaluation of cognitive function in healthy older subjects treated with fesoterodine.Influence of the Short-term Intake of High Doses of Solifenacin and Trospium on Cognitive Function and Health-Related Quality of Life in Older Women With Urinary Incontinence.The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis.
P2860
Q26746914-7983EC23-1175-4F0D-BD74-008DD332C047Q28084637-6A7B907F-E1AA-4075-AFAA-365CABDBC8A5Q30373008-C1F5D663-E1E4-4394-809F-9A813AE0B520Q33696642-9E7C96C0-90CB-4087-A5F9-CB7C2B97E408Q34351806-D16D384B-F1FD-413E-8485-024CD18D3C51Q34820091-28830295-334E-4F19-9448-55E4FE69E6AFQ35347702-1D63E746-8CFA-40C6-ABF8-8FD6DCEFD515Q36338313-F3B91FC1-808A-4120-B57E-0FA0A205CED8Q36568768-7D0B3F10-A8D9-4C56-AAD8-7B07DB67C205Q37399563-46DA89A5-591D-49E7-BD2C-2C0521880AE2Q37879017-739EDD3E-52E2-4C4D-BE0D-7533AEBA77C6Q38186569-8FEDE698-10C6-467F-90A0-33C0B0EA5F3DQ38202094-F2E4448A-1623-493F-873E-D988C8422E8CQ38352217-231D67C9-91CE-48E2-A0C6-D9C67E3AC0F6Q38635232-34084AFA-A0B1-4435-9825-662B38656317Q38669033-C5D882C6-F482-43E6-8C8B-97B3E6EC3B15Q38892831-2E3FA39E-97DD-4681-BB48-E9F0ED12EEE6Q39020998-F8665311-7DEF-4AF1-BF67-7A0E534F2761Q39342723-F66F14F0-BE69-47CA-BBFA-0EA712EAEF96Q47117943-9B5C1185-48B3-4E3C-B498-815829084E96Q47143545-B09CB319-AD38-4DF1-AD7B-15449C4BB733Q47993403-22DD87DF-5139-4DB6-8609-00B21445E5EFQ48054495-D34460D4-3FED-4638-9D35-E4731B037890Q50533611-4188A0D9-8998-4247-91A9-442CCB603FFDQ50753347-04D8047A-5649-4E98-8FC3-F0C97108016DQ53699301-3395AC32-215B-4128-B6C3-1E46764E5C6FQ55486735-F0C9CF84-4C76-4EDB-B06B-E867174057DC
P2860
Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Review of cognitive impairment ...... ients with overactive bladder.
@en
Review of cognitive impairment ...... ients with overactive bladder.
@nl
type
label
Review of cognitive impairment ...... ients with overactive bladder.
@en
Review of cognitive impairment ...... ients with overactive bladder.
@nl
prefLabel
Review of cognitive impairment ...... ients with overactive bladder.
@en
Review of cognitive impairment ...... ients with overactive bladder.
@nl
P2093
P2860
P1476
Review of cognitive impairment ...... ients with overactive bladder.
@en
P2093
P2860
P304
P356
10.1111/J.1742-1241.2010.02449.X
P577
2010-06-07T00:00:00Z